JOHN R MOORE
CIK 1191702 · General Counsel · last filed 2025-08-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$355.8K
Companies
2
Total Filings
53
Lifetime Open-Market Net
-$4.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EWTX | General Counsel | 10,214 | $34.83 | $355.8K | -$4.23M | 23 | 2025-08-14 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Director | — | — | — | $0 | 2 | 2016-09-14 |
Recent Filings · Page 2 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-08 | EWTX | Mixed | — | -$42.5K | EDGAR |
| 2022-08-10 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2022-08-05 | EWTX | Mixed | — | -$73.6K | EDGAR |
| 2022-07-07 | EWTX | Mixed | — | -$64.9K | EDGAR |
| 2022-06-21 | EWTX | Mixed | — | -$349.3K | EDGAR |
| 2022-06-15 | EWTX | Mixed | — | -$141.0K | EDGAR |
| 2022-06-10 | EWTX | Mixed | — | -$156.5K | EDGAR |
| 2022-06-07 | EWTX | Mixed | — | -$225.6K | EDGAR |
| 2022-05-18 | EWTX | Sell (S) | −10,800 | -$80.1K | EDGAR |
| 2022-05-03 | EWTX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.